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Abstract Blastocystis hominis is the most common intes-
tinal parasite in humans. An extensive genetic variability
has been described recently in B. hominis isolates. The aim
of this study was to analyze genotypes of B. hominis
isolates obtained from the healthy individuals and patients
with irritable bowel syndrome-diarrhea (IBS-D). The
patients with IBS-D were enrolled from gastroenterology
outpatient department at the Aga Khan University Hospital.
History and physical examination was done. Stool micros-
copy, culture, and polymerase chain reaction for B. hominis
genotyping were carried out. The study included 158
patients with IBS-D, mean age 41±15, age range 16–
83 years, and male/female ratio of 109:49. One hundred
fifty-seven (49.8%) were taken as healthy control. The
dominant B. hominis genotypes were genotype 1 in 87
(65%) and type 3 in 49 (37%). In IBS-D, genotype 1 was
present in 75 (86%; P<0.001) compared to 12 (14%) in
controls while type 3 was present in 23 (47%) compared to
26 (53%) in controls (P<0.001), respectively. Infection
with single genotype of B. hominis was present in 70 (73%)
with IBS-D and in 26 (27%) in control group while with
multiple genotypes in 25 (64%) in IBS-D and 14 (36%) in
control group (P=0.30), respectively. Majority of our
patients had typeable B. hominis infection. The genotype
of B. hominis in IBS-D was type 1 while in control
genotype 3 was predominant.
Introduction
Blastocystis hominis is a common intestinal protozoan
parasite of humans and many animals. It has a worldwide
distribution and is often the most commonly isolated
organism found in human stools. The prevalence and
incidence of human Blastocystis infections may be more
common than is known. It demonstrates morphological
diversity and the commonly used diagnostic techniques
such as light microscopy of fecal smears, concentrates, or
permanently stained smears that have low sensitivity
(Stensvold et al. 2006). Culture of B. hominis which is
more sensitive for detection of the B. hominis in fecal
samples is not routinely done in many laboratories. Despite
years of study, the pathogenic role of B. hominis is still
regarded by some as controversial as it is frequently found
not only in individuals with enteric symptoms but also in
apparently healthy and asymptomatic subjects (Tan et al.
2002). Extensive genetic diversity was demonstrated
among human B. hominis by various molecular techniques
(Clark 1997; Hoevers et al. 2000; Yoshikawa et al. 2004c).
It is thought that establishing relevant genotypic differences
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between the asymptomatic and symptomatic isolates should
assist in determining the pathogenicity of Blastocystis by
clearly assigning symptoms to its genotype. Several
methods that include arbitrarily primed polymerase chain
reaction (PCR), subtype-specific sequence-tagged-site
(STS) primers, have been developed and used in several
studies to detect genetic variations (Arisue et al. 2003;
Yoshikawa et al., 2003). This PCR-based technique is
currently being used for typing B. hominis isolates from
humans and animals (Abe et al. 2003c; Li et al. 2007b; Yan
et al. 2006; Yoshikawa et al. 2004c).
In a previous study in Pakistan, the prevalence of B.
hominis infection was determined in different age and sex
groups (Haider and Baqai 2008). Two hundred and thirty
fecal samples were collected from patients with gastroin-
testinal symptoms, and direct microscopy was used with
formol-ether concentration method. Parasites were detected
in 161 (70%) of patients with B. hominis present in 31%
(Haider and Baqai 2008). In another study, the prevalence
of intestinal parasitic infections was 53% among children 1
to 5 years old (Mehraj et al. 2008). Giardia lamblia was the
most common parasite followed by Ascaris lumbricoides,
B. hominis, and Hymenolepis nana (Mehraj et al. 2008).
These studies did not examine subtypes of Blastocystis
isolates, which is important as it has been proposed that
genetically different genotype (subtype) may be correlated
with pathogenic potential (Hussein et al. 2008; Tan 2008;
Yan et al. 2006). The aim of this study was to analyze
genotypes of B. hominis isolates obtained from patients
with irritable bowel syndrome-diarrhea (IBS-D) as defined
by Rome III criteria and healthy controls by in vitro culture
and PCR using seven kinds of STS primers and to
determine the correlation between the genotype and
symptomatology.
Material and methods
Sources and isolates of B. hominis
A total of 315 stool samples were obtained from patients
with IBS-D 158 (50.2%) and healthy controls 157 (49.8%)
who attended the gastroenterology outpatient clinic at the
Aga Khan University, Karachi between September 2007
and November 2009, respectively. In IBS-D group patients
presented with abdominal pain or discomfort associated
with diarrhea. The Rome III criteria for IBS-D states at least
12 weeks or more, which need not be consecutive, in the
preceding 12 months of stool frequency greater than three
bowel movements per day, abnormal stool form, e.g., loose/
watery stool and abnormal stool passage, i.e., urgency
(Longstreth et al. 2006). In control group, there were
healthy volunteers or those with upper abdominal discom-
fort not suggestive of IBS. These patients underwent
thorough history, physical examination, complete blood
count, erythrocyte sedimentation rate, liver function tests,
blood urea nitrogen, creatinine, electrolytes, stool micros-
copy, culture, and PCR for genotyping of B. hominis. The
study was approved by the institutional ethics review
committee. Technologists were unaware of the classifica-
tion status of the patients. All the stool specimens for
microscopy and culture of B. hominis were processed by
the same technicians, and a note was made for presence of
other parasites such as G. lamblia, Entamoeba histolytica,
etc. A microbiological investigation was also performed to
detect Salmonella spp., Campylobacter jejuni, Clostridium
difficile, and Vibrio cholerae. However, a viral screen was
not performed on stool specimens obtained in view of cost
limitations.
Microscopy of fecal smear
Fecal sample microscopy was done as described before
(Zaman and Khan 1994). Briefly, approximately 2 mg of
feces was thoroughly emulsified on a glass slide in one
drop of physiologic saline and covered with a cover slip. A
similar preparation was made on another slide using
Lugol’s iodine. These preparations were examined under
both the low power (×10) and high dry (×40) objectives.
Culture of feces
Cultures were done by inoculating approximately 50 mg of
feces into Jones’ medium. For culturing B. hominis, Jones
medium without starch was used (Zaman and Khan 1994).
The cultures were incubated at 37°C and examined after 2–
3 days. The sediment was examined under both the low
power (×10) and high dry (×40) objectives. The positive
samples were subcultured for another 3 days using fresh
media.
Extraction of genomic DNA
Genomic DNA of Blastocystis was extracted by using Stool
DNA Extraction kit (Qiagen) according to the manufac-
turer's protocol. Extracted DNA was stored at −20°C until
PCR was carried out for B. hominis genotyping.
Genotyping by PCR with STS primers
Seven kinds of STS primers developed for typing the
Blastocystis isolates were used as described previously
(Abe et al. 2003a, b, c; Li et al. 2007a, b; Yan et al. 2006;
Yoshikawa et al. 1998, 2000, 2003). Seven standardized
subtype-specific STS primers were used, namely SB83
(351 bp) for subtype 1, SB340 (704 bp) for subtype 2,
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SB227 (526 bp) for subtype 3, SB337 (487 bp) for subtype
4, SB336 (317 bp) for subtype 5, SB332 (338 bp) for
subtype 6, and SB155 (650 bp) for subtype 7 (Yoshikawa et
al. 2003), according to a recent classification terminology
(Stensvold et al. 2007). Typing of the Blastocystis isolates
was conducted through PCR amplification on the basis of
the presence or absence of the products within parallel
control PCR amplification. The PCR conditions consisted
of one cycle denaturing at 94°C for 3 min, 30 cycles
including annealing at 59°C for 30 s, extending at 72°C for
60 s, denaturing at 94°C for 30 s, and additional cycle with
a 5-min chain elongation at 72°C (PCR System 9700,
Perkin Elmer, USA). The PCR products and molecular
markers were electrophoresed in 2% agarose gel with Tris–
acetate–EDTA electrophoresis buffer. The size markers
were 100-bp ladder (Promega, USA). The PCR amplifica-
tion for each primer pair was repeated at least thrice. Bands
were visualized by the imaging system (Gel Doc 2000, Gel
Documentation System, Bio Rad, UK) after being stained
with ethidium bromide.
Statistical method
Results are expressed as mean ± standard deviation for
continuous variables (e.g., age) and number (percentage)
for categorical data (e.g., gender, stool culture, diarrhea,
etc.). Univariate analysis was performed by using the
independent sample t test. Pearson Chi-square test and
Fisher’s exact test were also used whenever appropriate. A
P value of <0.05 was considered as statistically significant.
All P values were two sided. Statistical interpretation of
data was performed by using the computerized software
program SPSS version 16.0.
Results
Of the 315 enrolled, 158 (50.2%) had IBS-D while 157
(49.8%) were controls. The symptoms consisted of diarrhea
in 158 (50%), abdominal pain in 43 (14%), and no
gastrointestinal symptoms in 114 (36%). In fecal samples
examined, 119 (38%) were positive for B. hominis on stool
microscopy and 133 (42%) on stool culture (Table 1). Stool
microscopy was significantly positive for B. hominis in
patients with IBS-D, 87 (73%; P<0.001) compared to 32
(27%) in control (Table 1). Stool culture was also
significantly positive for B. hominis in patients with IBS-
D, 95 (71%; P<0.001) compared to 38 (29%) in control
(Table 1).
Identification of B. hominis genotypes by PCR
In IBS-D, B. hominis subtype 1 infection was present in 75
(86%; P<0.001) compared to 12 (14%) in controls while
subtype 3 was present in 23 (47%) with IBS-D compared to
26 (53%) in controls (P<0.001; Table 2).
Genotypes associated with groups
Blastocystis infection with single genotype was present in
96 (30.5%) while with two or more genotypes in 39
(12.5%). B. hominis infection with single genotype was
seen in 70 (73%) with IBS-D compared to 26 (27%) in
control while infection with two or more B. hominis
subtypes were present in 25 (64%) with IBS-D and 14
(36%) in control (P=0.30). B. hominis infection with single
or multiple subtypes did not demonstrate age and gender
predisposition.
Table 1 The sequence-tagged site (STS) primer used
Subtypes STS primer Product size (bp) Sequences of primers GenBank accession no.
1 SB83 351 F-GAAGGACTCTCTGACGATGA AF166086
R-GTCCAAATGAAAGGCAGC
2 SB155 650 F-ATCAGCCTACAATCTCCTC AF166087
R-ATCGCCACTTCTCCAAT
3 SB227 526 F-TAGGATTTGGTGTTTGGAGA AF166088
R-TTAGAAGTGAAGGAGATGGAAG
4 SB332 338 F-GCATCCAGACTACTATCAACATT AF166091
R-CCATTTTCAGACAACCACTTA
5 SB340 704 F-TGTTCTTGTGTCTTCTCAGCTC AY048752
R-TTCTTTCACACTCCCGTCAT
6 SB336 317 F-GTGGGTAGAGGAAGGAAAACA AY048751
R-GAACAAGTCGATGAAGTGAGAT
7 SB337 487 F-GTCTTTCCCTGTCTATTCTGCA AY048750
R-AATTCGGTCTGCTTCTTCTG
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Discussion
In this study, prevalence of B. hominis infection in IBS-D
was 71%, which superseded the 29% seen in control
(Table 1). This is consistent with our previous study where
an increase in incidence of B. hominis infection was
demonstrated in association with IBS compared to healthy
population (Yakoob et al. 2004). However, this is also in
contrast to other local studies in symptomatic patients with
diarrhea that described a B. hominis prevalence of 31% in
adults (Haider and Baqai 2008) and 53% among children 1
to 5 years old (Mehraj et al. 2008). However, in both
studies, culture of B. hominis that is known to be more
sensitive than other routine parasitological examination
techniques (Windsor et al. 2002) was not carried out.
Therefore, the actual prevalence of B. hominis might be
higher than reported in these studies (Mehraj et al. 2008;
Haider and Baqai 2008). This study showed that all the
seven B. hominis genotypes based on STS primers were
found in Pakistan (Table 2). B. hominis subtypes 1 and 3
were predominant. Blastocystis subtypes 2, 4 5, 6, and 7
infection were also demonstrated in our patient and controls
varying from 2.5% to 3% (Table 2). Subtype 1 was
commonly found in IBS-D while subtype 3 was equally
common in patients with IBS-D and in the controls. In
individual patients, Blastocystis subtypes 1 and 3 were also
common as the cause of multiple genotype infection. B.
hominis infection with single subtype was common
compared to one with multiple subtypes. These results are
in keeping with Yoshikawa et al. (2004a) who, using STS
primers, examined five populations of human B. hominis
isolates obtained from Japan, Pakistan, Bangladesh, Ger-
many, and Thailand. The most dominant genotype among
four populations was subtype 3 varying from 41.7% to
92.3% followed by among four populations excluding
IBS-D Control P value
n=158 (50.2) n=157 (49.8)
Age Mean ± SD 41±15 42±14
Range 16–83 15–75
Gender Male 109 (69) 104 (66)
Female 49 (31) 53 (34)
Stool microscopy for B. hominis Positive 87 (73) 32 (27) <0.001
Negative 71 (36) 125 (64)
Culture for B. hominis Positive 95 (71) 38 (29) <0.001
Negative 63 (35) 119 (65)
Genotype
Positive
Type 1 n=87 75 (86) 12 (14) <0.001
Type 2 n=10 6 (60) 4 (40) 0.487
Type 3 n=49 23 (47) 26 (53) <0.001
Type 4 n=8 6 (75) 2 (25) 1
Type 5 n=7 3 (43) 4 (57) 0.197
Type 6 n=6 3 (50) 3 (50) 0.365
Type 7 n=10 5 (50) 5 (50) 0.282
Negative 181 64 (35) 117 (65)
Untypeable 2 2 (100) 0
Table 2 Details of patients en-
rolled in the study
Univariate analysis was per-
formed using the independent
sample t test. Pearson Chi-
square test and Fisher's exact
test were also used whenever
appropriate. A P value of <0.05
was considered as statistically
significant. Number and per-
centage=n (percent).










1 (9) 1 (7) Bangladesh
3 (91) 3 (93)
Yan et al. 2006 1 3 China
Hussein et al. 2008 1 (28.6) 2 (25) Egypt
3 (57.1) 3 (50)
4 (14.3) 4 (25)
Tan 2008 1 3 Malaysia
Dogruman-Al
et al. 2008
3 (59) 3 (48) Turkey
2
1
Eroglu et al. 2009 1 3, 2 Turkey
This study 1 (86) 3 (53) Pakistan
3 (47) 1 (14)
5 (43) 4 (57)
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Thailand, which was either subtype 1 (7.7–25.0%) or
subtype 4 (10.0–22.9%). However, in this study, limited
number of isolates was examined from Pakistan to draw
any conclusion regarding B. hominis subtypes found in our
population.
The implications of this study are that Blastocystis subtype
1 infection was common in the IBS-D population. However,
presence of subtype 3 in this group does not necessarily
mean that it is also associated with symptoms though there
have been studies that demonstrated subtype 3 commonly
associated with subtype 1 (Yoshikawa et al. 2004a; Table 3).
Hussein et al. (2008), in their study of experimental infection
in animals with human Blastocystis isolates, demonstrated
that subtype 1 was associated with elevated pathogenicity.
Recently, Yan et al. (2006) also demonstrated predominant
subtype 1 in a group of symptomatic patients with
Blastocystis. In this study, control subjects were mostly
healthy without symptoms that are suggestive of IBS-D, and
in them, subtype 3 was predominant followed by subtype 1
(Table 3). Blastocystis subtype 5 infections which indicate
zoonosis was equally common in the control and IBS-D
groups (Table 2; Yan et al. 2007). This subtype 5 infection in
our subjects might be explained on the basis that we are a
developing country with a high incidence of infections
transmitted by feco-oral route due to unavailability of clean
water for usage among many other factors (Zaman and Khan
1994). The frequency of mixed infections with different
subtypes was 39 (12.4%) with predominance of mixed
infection by subtypes 1 and 3 in 18 (6%). Other studies have
also reported low prevalence of mixed infections with
different subtypes (Yan et al. 2006; Li et al. 2007a, b;
Yoshikawa et al. 2004b) suggesting geographical variation.
This is the first investigation of molecular epidemiology
of human Blastocystis in Pakistan, and it indicates the
predominance of subtype 1 and 3 among human cases, as in
other regions of the world.
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